161 related articles for article (PubMed ID: 38339941)
1. Imaging Biomarkers in Prodromal and Earliest Phases of Parkinson's Disease.
Theis H; Pavese N; Rektorová I; van Eimeren T
J Parkinsons Dis; 2024 Feb; ():. PubMed ID: 38339941
[TBL] [Abstract][Full Text] [Related]
2. Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease.
Meles SK; Oertel WH; Leenders KL
Mol Med; 2021 Sep; 27(1):111. PubMed ID: 34530732
[TBL] [Abstract][Full Text] [Related]
3. Neuroimaging Advances in Parkinson's Disease and Atypical Parkinsonian Syndromes.
Saeed U; Lang AE; Masellis M
Front Neurol; 2020; 11():572976. PubMed ID: 33178113
[TBL] [Abstract][Full Text] [Related]
4. Emerging Neuroimaging Biomarkers Across Disease Stage in Parkinson Disease: A Review.
Mitchell T; Lehéricy S; Chiu SY; Strafella AP; Stoessl AJ; Vaillancourt DE
JAMA Neurol; 2021 Oct; 78(10):1262-1272. PubMed ID: 34459865
[TBL] [Abstract][Full Text] [Related]
5. Translational molecular imaging and drug development in Parkinson's disease.
Haider A; Elghazawy NH; Dawoud A; Gebhard C; Wichmann T; Sippl W; Hoener M; Arenas E; Liang SH
Mol Neurodegener; 2023 Feb; 18(1):11. PubMed ID: 36759912
[TBL] [Abstract][Full Text] [Related]
6. Prodromal PD: A new nosological entity.
Schaeffer E; Postuma RB; Berg D
Prog Brain Res; 2020; 252():331-356. PubMed ID: 32247370
[TBL] [Abstract][Full Text] [Related]
7. Four-Year Follow-up of [
Kogan RV; Janzen A; Meles SK; Sittig E; Renken RJ; Gurvits V; Mayer G; Leenders KL; Oertel WH;
Mov Disord; 2021 Jan; 36(1):230-235. PubMed ID: 32909650
[TBL] [Abstract][Full Text] [Related]
8. The Concept of Prodromal Parkinson's Disease.
Mahlknecht P; Seppi K; Poewe W
J Parkinsons Dis; 2015; 5(4):681-97. PubMed ID: 26485429
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers in Parkinson's disease (recent update).
Sharma S; Moon CS; Khogali A; Haidous A; Chabenne A; Ojo C; Jelebinkov M; Kurdi Y; Ebadi M
Neurochem Int; 2013 Sep; 63(3):201-29. PubMed ID: 23791710
[TBL] [Abstract][Full Text] [Related]
10. Multimodal brain and retinal imaging of dopaminergic degeneration in Parkinson disease.
Lee JY; Martin-Bastida A; Murueta-Goyena A; Gabilondo I; Cuenca N; Piccini P; Jeon B
Nat Rev Neurol; 2022 Apr; 18(4):203-220. PubMed ID: 35177849
[TBL] [Abstract][Full Text] [Related]
11. The role of neuroimaging in Parkinson's disease.
Bidesi NSR; Vang Andersen I; Windhorst AD; Shalgunov V; Herth MM
J Neurochem; 2021 Nov; 159(4):660-689. PubMed ID: 34532856
[TBL] [Abstract][Full Text] [Related]
12. Imaging of Substantia Nigra in Parkinson's Disease: A Narrative Review.
Feraco P; Gagliardo C; La Tona G; Bruno E; D'angelo C; Marrale M; Del Poggio A; Malaguti MC; Geraci L; Baschi R; Petralia B; Midiri M; Monastero R
Brain Sci; 2021 Jun; 11(6):. PubMed ID: 34207681
[TBL] [Abstract][Full Text] [Related]
13. Study protocol of the DUtch PARkinson Cohort (DUPARC): a prospective, observational study of de novo Parkinson's disease patients for the identification and validation of biomarkers for Parkinson's disease subtypes, progression and pathophysiology.
Boertien JM; van der Zee S; Chrysou A; Gerritsen MJJ; Jansonius NM; Spikman JM; van Laar T;
BMC Neurol; 2020 Jun; 20(1):245. PubMed ID: 32534583
[TBL] [Abstract][Full Text] [Related]
14. Clinical and Imaging Markers of Prodromal Parkinson's Disease.
Hustad E; Aasly JO
Front Neurol; 2020; 11():395. PubMed ID: 32457695
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging markers for early diagnosis of Parkinson's disease.
Marino S; Ciurleo R; Di Lorenzo G; Barresi M; De Salvo S; Giacoppo S; Bramanti A; Lanzafame P; Bramanti P
Neural Regen Res; 2012 Mar; 7(8):611-9. PubMed ID: 25745453
[TBL] [Abstract][Full Text] [Related]
16. Imaging Markers in Genetic Forms of Parkinson's Disease.
Droby A; Thaler A; Mirelman A
Brain Sci; 2023 Aug; 13(8):. PubMed ID: 37626568
[TBL] [Abstract][Full Text] [Related]
17. Multimodal dopamine transporter (DAT) imaging and magnetic resonance imaging (MRI) to characterise early Parkinson's disease.
Porter E; Roussakis AA; Lao-Kaim NP; Piccini P
Parkinsonism Relat Disord; 2020 Oct; 79():26-33. PubMed ID: 32861103
[TBL] [Abstract][Full Text] [Related]
18. Regional locus coeruleus degeneration is uncoupled from noradrenergic terminal loss in Parkinson's disease.
Doppler CEJ; Kinnerup MB; Brune C; Farrher E; Betts M; Fedorova TD; Schaldemose JL; Knudsen K; Ismail R; Seger AD; Hansen AK; Stær K; Fink GR; Brooks DJ; Nahimi A; Borghammer P; Sommerauer M
Brain; 2021 Oct; 144(9):2732-2744. PubMed ID: 34196700
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal Change of DAT SPECT in Parkinson's Disease and Multiple System Atrophy.
Sakakibara S; Hashimoto R; Katayama T; Kenjyo M; Yokokawa Y; Saito Y; Hirakawa A; Ito M; Nakamura T; Hara K; Hashizume A; Aiba I; Inukai A; Katsuno M
J Parkinsons Dis; 2020; 10(1):123-130. PubMed ID: 31707374
[TBL] [Abstract][Full Text] [Related]
20. The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson's disease.
Biondetti E; Santin MD; Valabrègue R; Mangone G; Gaurav R; Pyatigorskaya N; Hutchison M; Yahia-Cherif L; Villain N; Habert MO; Arnulf I; Leu-Semenescu S; Dodet P; Vila M; Corvol JC; Vidailhet M; Lehéricy S
Brain; 2021 Nov; 144(10):3114-3125. PubMed ID: 33978742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
